Asia Pacific Digital Therapeutics Market – Industry Analysis and Forecast (2022-2027)

Asia Pacific Digital Therapeutics Market is expected to reach US $ 8725.39 Mn by 2027, at a CAGR of 23.30% during the forecast period. Asia Pacific Digital Therapeutics Market To know about the Research Methodology :- Request Free Sample Report The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Asia Pacific Digital Therapeutics Market is segmented by sales channel, application, and geography. Sales channel segment is bifurcated as B2B and B2C.by application market is divided into Preventive Applications, Treatment/Care-Related Applications. Geography wise market is divided into Asia Pacific, China, Japan, India, South Korea, Australia, Others. Digital Therapeutics stands for health or social care interventions delivered through a smart device to support healthy behaviours and provide therapeutic effects and can be used to treat type II diabetes, Alzheimer’s disease, dementia, congestive heart failure, chronic obstructive pulmonary disease, and asthma. Technological advancements and rising focus on preventive healthcare are trending the overall Global Digital Therapeutics Market. However, lack of awareness and access to digital therapeutics programs in developing countries will restrain the market growth. Based on Sales channel, B2B segment is expected to lead the market growth. This growth is attributed to rising adoption of digital therapeutics in this segment, especially among payers and employers. On the basis of Application, Preventive application segment is expected to dominate the market growth owing to, increasing government initiatives to increase the focus on preventive healthcare and a rising consensus among policy makers. China, India, Japan, South Korea and Australia are some of the key countries that been the major contributors of the growth of Digital Therapeutics market in Asia Pacific region. Continuous reforms in countries to address lack of proper infrastructure and maintain sustainable growth through financial inclusion in this region will fuel the Digital Therapeutics Market in APAC region.

Asia Pacific Digital Therapeutics Market Scope: Inquire before buying

Asia Pacific Digital Therapeutics Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2027
Historical Data: 2017 to 2021 Market Size in 2021: US $ 2483.17 Mn.
Forecast Period 2022 to 2027 CAGR: 23.30% Market Size in 2027: US $ 8725.39 Mn.
Segments Covered: by Product • B2B • B2C
by Type • Preventive Applications • Treatment/Care-Related Applications

Asia Pacific Digital Therapeutics Market, by Countries:

• Asia Pacific • China • Japan • India • South Korea • Australia • Others

Asia Pacific Digital Therapeutics Market Key Players

Evolent Health, Inc. • Pear Therapeutics, Inc. • WellDoc Inc. • Nanobiosym, Inc. • Twine Health, Inc. • Mango Health Inc. • Canary Health Inc. • 2morrow Inc. • Propeller Health • Ginger.Io, Inc. • Noom Inc. • Livongo Health • Omada Health, Inc. • Proteus Digital Health, Inc. • Smartpatient gmbh • Wellthy Therapeutics Pvt Ltd • SAMSUNG • ResMed • Mindstrong, Inc.

Frequently Asked Questions:

1. Which region has the largest share in Asia Pacific Digital Therapeutics Market? Ans: Asia Pacific region held the highest share in 2021. 2. What is the growth rate of Asia Pacific Digital Therapeutics Market? Ans: The Asia Pacific Digital Therapeutics Market is expected to grow at a CAGR of 23.30% during forecast period 2022-2027. 3. What is scope of the Asia Pacific Digital Therapeutics market report? Ans: Asia Pacific Digital Therapeutics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Asia Pacific Digital Therapeutics market? Ans: The important key players in the Asia Pacific Digital Therapeutics Market are – Evolent Health, Inc., Pear Therapeutics, Inc., WellDoc Inc., Nanobiosym, Inc., Twine Health, Inc., Mango Health Inc., Canary Health Inc., 2morrow Inc., Propeller Health, Ginger.Io, Inc., Noom Inc., Livongo Health, Omada Health, Inc., Proteus Digital Health, and Inc 5. What is the study period of this market? Ans: The Asia Pacific Digital Therapeutics Market is studied from 2021 to 2027.

Asia Pacific Digital Therapeutics Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Asia Pacific Digital Therapeutics Market Size, by Market Value (US$ Mn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 5. Asia Pacific Digital Therapeutics Market Analysis and Forecast 5.1. Asia Pacific Digital Therapeutics Market Analysis and Forecast 5.2. Asia Pacific Digital Therapeutics Market Size& Y-o-Y Growth Analysis 5.2.1. Asia Pacific 6. Asia Pacific Digital Therapeutics Market Analysis and Forecast, by Sale channel 6.1. Introduction and Definition 6.2. Key Findings 6.3. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Sale channel 6.4. Market Size (US$ Mn) Forecast, by Sale channel 6.5. Digital Therapeutics Market Analysis, by Sale channel 6.6. Asia Pacific Digital Therapeutics Market Attractiveness Analysis, by Sale channel 7. Asia Pacific Digital Therapeutics Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Application 7.3. Market Size (US$ Mn) Forecast, by Application 7.4. Asia Pacific Digital Therapeutics Market Analysis, by Application 7.5. Asia Pacific Digital Therapeutics Market Attractiveness Analysis, by Application 8. Asia Pacific Digital Therapeutics Market Analysis, by Region 8.1. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Region 8.2. Market Size (US$ Mn) Forecast, by Region 8.3. Asia Pacific Digital Therapeutics Market Attractiveness Analysis, by Region 9. Asia Pacific Digital Therapeutics Market Analysis 9.1. Key Findings 9.2. Asia Pacific Digital Therapeutics Market Overview 9.3. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Sale channel 9.4. Asia Pacific Digital Therapeutics Market Forecast, by Sale channel 9.4.1. B2B 9.4.2. B2C 9.5. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Application 9.6. Asia Pacific Digital Therapeutics Market Forecast, by Application 9.6.1. PREVENTIVE APPLICATIONS 9.6.2. Treatment/Care-Related Applications 9.7. Asia Pacific Digital Therapeutics Market Value Share Analysis, by Country 9.8. Asia Pacific Digital Therapeutics Market Forecast, by Country 9.8.1. China, 9.8.2. India, 9.8.3. Japan, 9.8.4. ASEAN, 9.8.5. Rest of Asia Pacific, 9.9. Asia Pacific Digital Therapeutics Market Analysis, by Country/ Sub-region 9.10. China Digital Therapeutics Market Forecast, by Sale channel 9.10.1. B2B 9.10.2. B2C 9.11. China Digital Therapeutics Market Forecast, by Application 9.12. PREVENTIVE APPLICATIONS 9.12.1. Treatment/Care-Related Applications 9.13. India Digital Therapeutics Market Forecast, by Sale channel 9.13.1. B2B 9.13.2. B2C 9.14. India Digital Therapeutics Market Forecast, by Application 9.15. PREVENTIVE APPLICATIONS 9.15.1. Treatment/Care-Related Applications 9.16. Japan Digital Therapeutics Market Forecast, by Sale channel 9.16.1. B2B 9.16.2. B2C 9.17. Japan Digital Therapeutics Market Forecast, by Application 9.18. PREVENTIVE APPLICATIONS 9.18.1. Treatment/Care-Related Applications 9.19. ASEAN Digital Therapeutics Market Forecast, by Sale channel 9.19.1. B2B 9.19.2. B2C 9.20. ASEAN Digital Therapeutics Market Forecast, by Application 9.21. PREVENTIVE APPLICATIONS 9.21.1. Treatment/Care-Related Applications 9.22. Rest of Asia Pacific Digital Therapeutics Market Forecast, by Sale channel 9.22.1. B2B 9.22.2. B2C 9.23. Rest of Asia Pacific Digital Therapeutics Market Forecast, by Application 9.24. PREVENTIVE APPLICATIONS 9.24.1. Treatment/Care-Related Applications 9.25. Asia Pacific Digital Therapeutics Market Attractiveness Analysis 9.25.1. By Sale channel 9.25.2. By Application 9.26. PEST Analysis 10. Company Profiles 10.1. Market Share Analysis, by Company 10.2. Competition Matrix 10.3. Company Profiles: Key Players 10.3.1. Evolent Health, Inc. 10.3.1.1. Company Overview 10.3.1.2. Financial Overview 10.3.1.3. Business Strategy 10.3.1.4. Recent Developments 10.3.1.5. Stock Management Footprint 10.3.2 Evolent Health, Inc. 10.3.3. Pear Therapeutics, Inc. 10.3.4. WellDoc Inc. 10.3.5. Nanobiosym, Inc. 10.3.4. Twine Health, Inc. 10.3.5. Mango Health Inc. 10.3.6. Canary Health Inc. 10.3.7. 2morrow Inc. 10.3.8. Propeller Health 10.3.9. Ginger.Io, Inc. 10.3.10. Noom Inc. 10.3.11. Livongo Health 10.3.12. Omada Health, Inc. 10.3.13. Proteus Digital Health, Inc. 10.3.14. Smartpatient gmbh 10.3.15. Wellthy Therapeutics Pvt Ltd 10.3.16. SAMSUNG 10.3.17. ResMed 10.3.18. Mindstrong, Inc. 11. Primary Key Insights

About This Report

Report ID 7081
Category Information Technology & Telecommunication
Published Date Nov 2019
Updated Date April 2022
Contact Us